Company ProfilePremium

Hongkong Chinese Limited

Company Profile Analysis

Ticker: 0655.HK香港華人有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Hongkong Chinese Limited - Company showcase

Year Founded & Workforce

1992

23 Employees

Hongkong Chinese Limited logo

Hongkong Chinese Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Hongkong Chinese Limited Overview

Hongkong Chinese Limited is an investment holding company within the Riady family's Lippo Group. In economic terms it is a listed, leveraged holding vehicle for an indirect interest in Singapore-listed OUE Limited. HKC holds 50% of Lippo ASM Asia Property Limited (LAAPL). LAAPL owns about 92.05% of Fortune Crane Limited, which in turn controls about 73.44% of OUE. That gives HKC a derived look-through economic interest in OUE of roughly 33.8%. OUE is a Singapore real-estate, hospitality and healthcare group that controls OUE REIT, OUE Healthcare and a large stake in First REIT. The rest of HKC is small: a sliver of Hong Kong investment property, unsold units at Lippo Plaza Beijing, a Singapore development associate, treasury and securities positions, and project-management services. HKC carried HK$8.1bn in LAAPL at 30 June 2026 against a market value of about HK$0.76bn. Its reported results are therefore driven almost entirely by non-cash equity-accounted swings at OUE, especially OUE's exposure to the Chinese Mainland property market through Gemdale Properties and Investment.


The company's own description

The FY2025 Annual Report describes HKC as an investment holding company. Its subsidiaries, associates and joint ventures are engaged in investment holding, property investment, property development, hotel operation, healthcare services, project management, securities investment and treasury investment. The report states that the nature of these activities did not change materially during FY2025.

The company's stated business strategy is short. HKC describes its activities as diversified and says it aims for long-term sustainable growth that preserves and enhances shareholder value. It says it does this by selecting attractive investment opportunities to strengthen and extend its business scope while keeping financial management prudent and disciplined (FY2025 Annual Report, "Business Strategy").

Independent characterisation

HKC is better described as a closed-end, single-asset holding company than as an operating business. Three facts support this.

  1. Asset concentration. At 30 June 2026, interests in joint ventures were HK$8,306.5m out of total assets of HK$8,748.1m, or 95.0% (derived). Of this, HK$8,144.7m was the Group's total interest in LAAPL (1H2026 Interim Results, Notes 2 and 7).

  2. Revenue is mostly intra-group interest. FY2025 revenue was HK$53m. The property investment segment contributed 93% of it. That segment revenue consists mainly of interest on shareholder loans to the LAAPL group plus a small amount of rental income. In FY2025 the largest single customer accounted for 62% of revenue and the five largest for 84% (FY2025 AR, "Major Suppliers and Customers"). Given the loan structure, the largest customer is almost certainly the LAAPL group/Fortune Crane, although the report does not name it.

  3. Earnings are mostly equity-accounted. Between FY2021 and FY2025, "Earnings from equity investments" ranged from +HK$651.5m to −HK$1,197m. Operating income ranged only from HK$15m to HK$40m (StockAnalysis/S&P GMI).

Revenue model mix

Revenue type (1H2026)HKD Mn% of totalNotes
Interest income (loans/advances and other)11.8876.51H2025: 33.72. Fell after partial interest waiver on JV loans from 1 Jul 2025
Property rental income (operating leases)3.4121.91H2025: 3.59
Project management services (contracts with customers, Singapore)0.221.41H2025: 0.21
Dividend income0.020.2Unchanged
Other0.000.0—
Total15.53100.01H2025: 37.55

Source: 1H2026 Interim Results, Note 3.

There is no product sales, subscription or licensing revenue. Only about 1–2% of revenue is "revenue from contracts with customers" under HKFRS 15.

Value-chain position, customers and end-markets

Value-chain position: a capital provider and owner. HKC supplies equity and shareholder loans to the LAAPL/OUE structure and does not run operations itself.

Customer types: mainly related-party borrowers (JV entities). The other customers are commercial tenants of HK investment property and a Singapore client for project management.

End-markets reached through OUE: - Singapore Grade A office (OUE Bayfront, One Raffles Place, OUE Downtown Office)

  • Singapore hospitality (Hilton Singapore Orchard, Crowne Plaza Changi Airport) and retail (Mandarin Gallery)

  • Sydney office (19.9% of Salesforce Tower, from March 2026)

  • Asian healthcare (OUE Healthcare in Singapore, Chinese Mainland and Myanmar; First REIT in Singapore, Japan and Indonesia)

  • Chinese Mainland property, through OUE's 29.07% stake in Gemdale Properties and Investment (GPI)

Direct end-markets: Hong Kong property leasing (small), Beijing strata residential/commercial (Lippo Plaza remainders), and Singapore project management.

Strategy

Stated strategy (FY2025 Annual Report themes, paraphrased)

Diversified investment holding: The Group describes its business activities as diversified.

Long-term sustainable growth: that preserves and enhances shareholder value.

Selective investment: Choose attractive opportunities that strengthen and extend business scope.

Prudent, disciplined financial management: Repeated in the FY2025 and 1H2026 prospects sections as cautious management of assets and prudent capital management.

Chairman's message: Navigate tariff and geopolitical headwinds "with resilience and determination" (FY2025 Chairman's Statement), and exercise prudence in capital and expenditure management given the Middle East conflict.

No investor day is held. No medium-term financial targets or guidance are published (not publicly disclosed).

Strategic initiatives, last 24 months

DateInitiativeLevelStatus / significance
27 Dec 2024 → 2025Lippo Limited distribution in specie of HKC shares; Lippo Capital becomes direct holderShareholderCompleted by 31 Dec 2025. Raised the public float and simplified the chain
Sep 2025Lippo Limited privatised and delisted; Lippo becomes a "former holding company"GroupCompleted (scheme effective 23 Sep 2025)
From 1 Jul 2025Pro-rata cessation of interest on part of the shareholder loans to FCL (approx. S$312.41m waived from HKC side)HKC / JVCuts HKC revenue but also reduces JV losses. Group-neutral and a cash-relief measure for the JV
Dec 2025Governance refresh: Workforce Diversity Policy adopted; Audit and Nomination Committee terms of reference revised; Shareholders' Communication Policy revisedHKCImplemented
Mar 2026Dividend Policy revised; Anti-corruption Policy revisedHKCImplemented. Policy says no fixed payout ratio
Jun 2026Re-domiciliation from Bermuda to Hong Kong approved by shareholdersHKCPending other conditions. Rationale: lower cost and simpler administration
May 2025 → 2028Hotel Indigo Changi Airport (255 rooms, OUE 51%), Singapore's first zero-energy hotelOUEUnder construction
Dec 2025OUE buys an additional 19.32% of OUEH (to 89.68%)OUECompleted
Mar 2026OUE REIT acquires 19.9% of Salesforce Tower, SydneyOUE REITCompleted; first entry into Australia
Jun 2026Proposed sale of Crowne Plaza Changi Airport by OUE REIT to an OUE JVOUE / OUE REITSubject to unitholder EGM
Jun 2026First REIT phase-one divestment of 8 Indonesian hospitalsFirst REITUnitholder-approved; buyer approval pending
24 Aug 2026Proposed privatisation of OUEH at S$0.050 per share by scheme of arrangementOUEPending

Sustainability / ESG commitments

At HKC level: an Environmental Policy, an ESG Report (FY2025 AR pp.40–78), ESG risks integrated into ERM since 2018, and the Workforce Diversity Policy (Dec 2025). At OUE level: Green Mark upgrades for four OUE REIT assets in 2025, Singapore Sustainability Awards for CPCA and Hilton Singapore Orchard, and the zero-energy Hotel Indigo. No quantified emissions targets were retrieved for HKC.

Cost programmes / guidance

No formal cost programme or financial guidance has been published. Unallocated corporate expenses fell to HK$9.6m in 1H2026 from HK$10.6m in 1H2025.

Products & Services

HKC has no consumer "products". Its catalogue is a portfolio of assets and investee businesses. They are listed below by segment and then by the look-through holdings that drive value.

Direct holdings

SegmentAsset / offeringDescriptionCustomer / counterpartyLatest statusPricing model
Property investmentInvestment properties (HK$123.7m at 30 Jun 2026)Leased commercial propertyCommercial tenantsRental income HK$3.4m in 1H2026Operating leases
Property investmentShareholder loans to Fortune Crane LimitedS$380.42m (approx. HK$2,303m) outstanding at 31 Dec 2025, unsecured and repayable on demand; 2.25% p.a. but interest waived on approx. S$312.41m from 1 Jul 2025LAAPL groupInterest income from loans HK$11.4m in 1H2026 vs HK$31.2m in 1H2025Contractual interest
Property developmentLippo Plaza, Beijing (remaining units)Unsold properties held for sale (HK$67.0m) and properties under development (HK$20.6m)Retail buyers in BeijingSales described as stagnantUnit sales
Property developmentAssociate: developer of Marina Collection, Sentosa (Singapore)Associate that developed and sold flats; defendant in UOB litigation—Carrying value fell from HK$237.8m to HK$113.0m after the Aug 2026 judgment—
Property development (FY2025)Associate carrying an office-leasing businessImpairment provision taken in FY2025—Name not disclosed in retrieved extracts—
Treasury investmentMoney-market depositsCash and depositsBanksInterest income HK$0.49m in 1H2026Deposit interest
Securities investmentListed equities and other financial assetsFVTPL HK$2.5m current plus HK$3.0m non-current; FVOCI HK$0.06mMarketFV loss HK$0.53m in 1H2026Market price
OtherProject management servicesServices delivered in Singapore, recognised over timeOne client in SingaporeHK$0.22m in 1H2026Fee-based

Look-through portfolio via LAAPL → OUE Limited (principal value driver)

Business (OUE Group)Key assets / brandsDescription and recent statusSource
OUE REIT (approx. 49.92% LAAPL group interest, Jun 2026)OUE Bayfront; One Raffles Place; OUE Downtown Office; Hilton Singapore Orchard; Mandarin Gallery; Crowne Plaza Changi Airport; 19.9% of Salesforce Tower, SydneyOffice committed occupancy 95.4% and Mandarin Gallery 95.7% at 31 Dec 2025. Salesforce Tower stake completed Mar 2026 (100% committed occupancy at 30 Jun 2026). Green Mark Platinum for OUE Bayfront and OUE Downtown Office. Proposed sale of Crowne Plaza Changi Airport to an OUE JV announced Jun 2026, subject to unitholder approvalFY2025 AR; 1H2026 IR
HospitalityCrowne Plaza Changi Airport; Hilton Singapore Orchard; Hotel Indigo Changi Airport (255 rooms, OUE 51%)CPCA named "World's Best Airport Hotel" at the 2025 Skytrax awards for the 10th straight year. Hotel Indigo Changi Airport at Terminal 2, construction began May 2025, completion targeted 2028; billed as Singapore's first zero-energy hotelFY2025 AR
OUE Healthcare (OUEH; 89.68%)O2 Healthcare Group ("Lung Centre", Singapore); O2 SleepWell Laboratory (Mar 2026); hospital in Wuxi; Prince Bay Hospital, Shenzhen (JV, opened Jul 2026); three hospitals in Mandalay, Myanmar (JVs)OUE raised its stake by 19.32% in Dec 2025. Privatisation scheme at S$0.050 per share announced 24 Aug 2026FY2025 AR; 1H2026 IR
First REIT (approx. 45.81%)3 properties in Singapore, 14 in Japan, 14 in Indonesia (healthcare real estate)Phase-one sale of 8 Indonesian assets approved by unitholders Jun 2026, pending buyer-side approval1H2026 IR
GPI (29.07%, equity-accounted)Gemdale Properties and Investment, a Chinese Mainland property companyMain source of OUE's losses and impairments in FY2024–1H2026OUE FY2025 profit guidance; OUE 1H2026 results

Financial Narrative

Income statement

Notes:

  • EPS is net income divided by 1,998.28m shares; S&P shows HK$0.34 / 0.24 / 0.08 / −0.60 / −0.45.

  • No interim or final dividend for FY2024 or FY2025 (FY2025 AR). The FY2023 final dividend was paid in 2024 (2025 Interim Report, statement of changes in equity).

Revenue CAGR FY2021–FY2025 (derived): (53.19 / 81.09)^(1/4) − 1 = −10.0% per year.

Interim bridge.

Sources: 1H2025 Interim Report; Reuters/Tiger brief (29 Sep 2025); 1H2026 Interim Results.

Implied 2H2025 attributable loss (derived) = −891.65 − 199.47 = −HK$1,091m. Trailing twelve months to June 2026 = −HK$1,661m (S&P TTM).

Commentary.

Inflection: FY2023 was the last profitable year. Over FY2021–FY2023 the share of investee profits fell from HK$651.5m to HK$174.8m. In FY2024–FY2025 it turned sharply negative, as OUE took Chinese Mainland property losses through GPI, fair-value losses on investment property, and impairments.

FY2024 EBIT spike: operating income rose to HK$39.6m, an operating margin of 54%. The main cause was lower SG&A (HK$17.4m vs HK$34.4m in FY2023), on S&P's classification.

FY2025 revenue drop of 27%: interest income fell after the shareholders of a JV agreed to stop accruing interest on part of their shareholder loans pro rata from 1 July 2025 (FY2025 AR). The effect is economically neutral at group level, because HKC's share of JV losses falls correspondingly. Reported revenue, however, declines.

Finance costs: fell to HK$23m in FY2025 from HK$32m, on lower HIBOR (FY2025 AR). They were HK$10.9m in 1H2026.

Staff costs: rose to HK$18m in FY2025 from HK$11m (FY2025 AR), even though headcount was flat at 23. This partly reflects discretionary bonuses to the Chairman (HK$3.09m) and the CEO (HK$1.04m).

Balance sheet

Latest position (30 June 2026, HK$ m):

  • Total assets 8,748.1, of which interests in JVs 8,306.5 and associates 113.0

  • Cash 84.7; bank loans 506.7 (all non-current, HKD, floating rate); total liabilities 564.8

  • Equity attributable 8,167.7; NAV per share HK$4.1

  • Current ratio 3.8; gearing (borrowings / attributable equity) 6.2%

  • No charges on assets, no material contingent liabilities, and no capital commitments

Source: 1H2026 Interim Results.

Cash flow

Source: S&P GMI via StockAnalysis. No buybacks were made in FY2025 or 1H2026 (FY2025 AR; 1H2026 IR).

Commentary. Cash generation is structurally thin. HKC receives no dividends of note from LAAPL in the cash-flow data, and the interest it receives is now partly waived. In FY2022–FY2024 the company funded negative operating cash flow and dividends by drawing down bank debt, which rose from HK$273m to HK$501m. FY2025 operating cash flow turned positive at HK$31.7m. S&P does not break out the reason; plausible drivers are timing of interest receipts and working capital. FY2024 shows a HK$536m bank-loan refinancing: HK$501m was repaid and HK$536m newly drawn.

Ratios

Methodology:

  • ROE and ROA use the average of opening and closing balances for FY2022–FY2025.

  • The company reports a current ratio of 3.9 (FY2025) and 3.6 (FY2024), and gearing of 5.8% and 5.6%, which agree with the derived figures.

  • ROIC: S&P shows −0.06% on a TTM basis.

  • Cash conversion cycle: not meaningful. HKC has no trade receivables or payables of significance, and its "inventory" (properties held for sale) does not turn over.

Interpretation. Leverage at the HKC level is low, at about 6% gearing. However, interest is not covered by recurring operating earnings: EBIT/interest was 0.66x in FY2025 and negative on a TTM basis per S&P (−0.24x). Debt service relies on the cash buffer (HK$85–111m), on the interest still being received from the JV, and on the ability to refinance. The look-through leverage is materially higher. OUE reported net gearing of 53.8% at 31 December 2025 (The Edge Singapore), and LAAPL bank facilities are secured on listed shares it holds (1H2026 IR, Note 7).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts / servicesCarries share of results of

Property investment

Letting and resale of properties; interest on loans to JVs

Rental of HK/other investment property; JV shareholder-loan interest

Joint ventures (LAAPL → OUE)

Property development

Development and sale of properties

Remaining strata units at Lippo Plaza, Beijing

Associates (incl. the Singapore Marina Collection associate)

Treasury investment

Money-market investments

Bank deposits / money-market interest

—

Securities investment

Securities held for trading and long-term strategic purposes

Listed equities / debt securities

—

Other

Mainly project management services

Project management (Singapore client)

—

Revenue by Segment

SegmentFY2024FY2025

Property investment revenue (HKD Mn)

7050

All other segments combined revenue (HKD Mn, derived)

2.853.19

Total revenue (HKD Mn)

72.8553.19

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment profit before share of JV/associates

Segment profit before share of JV/associatesFY2024FY2025

Property investment segment profit (HKD Mn)

286

Property development segment result (HKD Mn)

-4-4

Revenue by Segment (1H2025–1H2026)

Segment (external revenue, HKD Mn)1H20251H2026

Property investment

34.7514.53

Property development

00

Treasury investment

2.550.49

Securities investment

0.020.02

Other

0.220.48

Total

37.5515.53

Revenue by Segment and Revenue by Segment (%)

Segment results (HKD Mn)1H20251H2026

Property investment

19.410.23

Property development

-1.74-1.67

Treasury investment

2.550.49

Securities investment

0.66-0.64

Other

-0.220.26

Total segment results

20.66-1.33

Unallocated corporate expenses

-10.58-9.62

Share of associates (in property development)

2.91-126.33

Share of joint ventures (in property investment)

189.10-432.10

Profit/(loss) before tax

202.09-569.37

Segment assets (HKD Mn)

Segment assets (HKD Mn)31 Dec 202530 Jun 2026

Property investment (ex-JV)

147.91151.07

Property development (ex-associates)

73.9875.72

Treasury investment

99.6272.19

Securities investment

6.015.48

Other

8.539.85

Interests in associates

237.81113.03

Interests in joint ventures

8,722.598,306.50

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (HKD Mn)

81.0971.7774.7972.8553.19

Revenue growth (%)

-26.30-11.494.21-2.61-26.99

Gross profit (HKD Mn)

77.3970.9371.9170.6151.17

Operating income / EBIT (HKD Mn)

18.8417.1018.6339.5915.19

EBITDA (HKD Mn)

24.7322.7724.7440.7316.47

Interest expense (HKD Mn)

12.1711.1026.5632.2223.12

Share of equity investees (HKD Mn)

651.50470.69174.77-1,197.00-871.94

Pre-tax income (HKD Mn)

654.19491.22158.99-1,194.00-891.84

Net income attributable (HKD Mn)

670.30488.77157.12-1,200.00-891.65

EPS basic = diluted (HK cents, derived)

33.524.57.9-60.1-44.6

Dividend per share (HK cents, S&P)

1.31.01.000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin metric (%)

Margin metric (%)FY2021FY2022FY2023FY2024FY2025

Gross margin

95.4498.8296.1596.9296.20

Operating margin

23.2423.8324.9154.3428.56

EBITDA margin

30.4931.7333.0755.9230.96

Net margin

826.62680.99210.07-1,647.19-1,676.47

Income Statement and Margin Analysis (%) (1H2024–1H2026)

Metric (HKD Mn)1H20241H20251H2026

Revenue

36.2037.5515.53

Share of JVs

-432.68189.10-432.10

Share of associates

10.022.91-126.33

Profit/(loss) attributable

-421.60199.47-569.49

EPS (HK cents)

-21.110.0-28.5

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (HKD Mn)

11,57011,22111,1589,5459,311

Long-term investments, mainly JV/associates (HKD Mn)

11,15910,76510,7809,2268,963

Cash and equivalents (HKD Mn)

122.21207.37145.4697.33110.93

Short-term debt incl. current leases (HKD Mn)

0.250.270.2700

Long-term debt (HKD Mn)

272.56456.11465.67501.47505.07

Total debt (HKD Mn)

272.81456.64465.94501.47505.07

Net debt (HKD Mn, S&P, net of cash and ST investments)

139.91248.96320.25404.08391.14

Total liabilities (HKD Mn)

349.42522.96529.09563.30568.46

Equity attributable to shareholders (HKD Mn)

11,20110,68010,6138,9678,727

Total equity incl. NCI (HKD Mn)

11,22110,69810,6298,9828,742

Goodwill and intangibles (HKD Mn)

00000

Working capital (HKD Mn)

181.29249.99186.19133.54155.04

Book value per share (HKD)

5.615.345.314.494.37

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (HKD Mn)

13.26-33.83-42.42-27.0131.66

Capital expenditure (HKD Mn, outflow)

0.540.761.762.840.17

Free cash flow (HKD Mn)

12.72-34.59-44.17-29.8631.49

Common dividends paid (HKD Mn)

34.9744.96019.980

Share buybacks (HKD Mn)

00000

Net debt issued / (repaid) (HKD Mn)

4.74179.755.7434.7410.00

Cash interest paid (HKD Mn)

20.037.4422.8331.6129.53

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE (%, derived)

6.04.51.5-12.3-10.1

ROA (%, derived)

5.84.31.4-11.6-9.5

Current ratio (x, derived)

3.965.694.583.623.90

Debt / total equity (%, derived)

2.44.34.45.65.8

Net debt / EBITDA (x, derived)

5.710.912.99.923.7

Interest coverage EBIT / interest (x, derived)

1.551.540.701.230.66

Asset turnover (x, derived)

0.0070.0060.0070.0070.006

Revenue by Region

Geographic market (HKD Mn)1H20251H2026

Republic of Singapore — project management revenue

0.2120.220

Revenue stream

Revenue streamEconomic geographyFY2025 materialityTrendDriver

Interest on loans to LAAPL/FCL

Singapore (borrower is a Singapore-centred JV; loans are SGD)

Dominant (~60–85% of revenue)

Declining sharply

Interest waiver on approx. S$312m of loans from 1 Jul 2025

Rental income

—

approx. HK$7m p.a. (1H2026 run-rate 3.4m)

Slightly declining

Leasing market

Lippo Plaza Beijing sales

Chinese Mainland

Nil sales recognised

Stagnant

Prolonged Mainland property correction

Treasury interest

Hong Kong

Small

Declining

Lower cash balances and rates

Project management

Singapore

approx. HK$0.4m p.a.

Stable

Single client

Valuation Snapshot

MetricValueDate / source

Last price

HK$0.38

Close 9 Oct 2026 (S&P via StockAnalysis)

Recent reference prices

HK$0.455 (31 Jul 2026); HK$0.45 (18 Aug 2026)

StockAnalysis

52-week change

+15.15%

S&P, as of 10 Oct 2026

50-day / 200-day moving average

HK$0.43 / HK$0.36

S&P

Beta (5-year)

0.45

S&P

20-day average volume

approx. 402,484 shares

S&P

Market capitalisation

approx. HK$759m

S&P

Enterprise value

approx. HK$1.19bn

S&P

Valuation Multiples

Multiple0655.HKComment

P/E (TTM)

n/m

Loss-making (TTM loss HK$1,661m)

EV/EBITDA (TTM)

n/m

TTM EBITDA −HK$4.1m

EV/Sales (TTM)

38.3x

Revenue is mostly intra-group interest

P/B

0.09x

Book value per share HK$4.09 (S&P) / HK$4.1 (company)

P/FCF (TTM)

21.6x

FCF HK$35.1m

Discount to NAV (derived)

approx. 91%

HK$0.38 vs HK$4.1

Market cap / LAAPL carrying value (derived)

approx. 9%

759 / 8,145

Per-Share Data and Dividends & Capital Returns

MetricFY2021FY2022FY2023FY2024FY2025

Dividend per share (HK cents, S&P rounded)

1.31.01.000

Dividends paid in cash (HKD Mn)

34.9744.96019.980

Buybacks (HKD Mn)

00000

Analyst Conclusions

Management guidance

Management gives no quantitative guidance. The 1H2026 prospects statement says the Group and its joint ventures will continue to manage their businesses, monitor their assets cautiously and exercise prudent capital management. It notes the upgraded Singapore forecast, slowing Mainland growth and rising downside risks from the Middle East conflict (1H2026 IR). No consensus forecasts exist.

Bull case

  1. Extreme asset backing. NAV is HK$4.1 per share against a HK$0.38 price, and HKC-level gearing is only 6.2%. Even after severe haircuts to LAAPL's HK$8.1bn carrying value, the equity is covered many times. Any event that bridges price to NAV is highly accretive.

  2. Investee operating recovery. OUE's core operations are growing: 1H2026 revenue rose 5.3%, with stronger hospitality and lower interest costs at OUE REIT. GPI losses already reduced the GPI carrying value through repeated impairments (S$20m in FY2025 and S$47m in 1H2026). Once the GPI drag is exhausted, the equity-accounted line could flip positive, as it did in FY2021–FY2023 (+HK$651m, +HK$471m, +HK$175m).

  3. Simplification and capital recycling. The Lippo Ltd delisting, the OUEH privatisation, the CPCA sale proposal, First REIT's deleveraging and HKC's re-domiciliation all point to active portfolio management. That could culminate in value crystallisation, whether through dividends or a holdco transaction.

Bear case

  1. Structural NAV discount is rational. HKC has paid no dividend since the FY2023 final. Revenue is collapsing as JV interest is waived. Interest cover is below 1x. Minorities have no route to the underlying value, so the discount may persist indefinitely.

  2. Earnings risk is not over. TTM losses are HK$1.66bn. GPI remains exposed to a Mainland property market the company itself describes as being in a prolonged structural correction. The UOB judgment shows that legacy liabilities can surprise on the downside: the award went from S$17.7m to S$76.1m.

  3. Controller-driven exit risk. The controlling family has a record of taking subsidiaries private, with Lippo Ltd in 2025 and OUEH proposed in 2026. A take-private of HKC at a modest premium to a deeply discounted price, rather than at a fraction of NAV, is a plausible adverse outcome for minorities. This is an inference from precedent, not a disclosed plan.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
Completion of re-domiciliation to Hong Kong2H2026–1H2027Cost savings; any bye-law changes affecting minorities
OUEH privatisation scheme vote2H2026Completion; cash outlay at OUE
OUE REIT EGM on Crowne Plaza Changi divestment2H2026Price versus book; use of proceeds
First REIT Indonesia divestment completion2H2026OUE group deleveraging
GPI results and further OUE impairmentsOUE FY2026 results (about Feb 2027)Size of share-of-loss line; residual GPI carrying value
HKC FY2026 resultsAbout March 2027Equity-accounted swing; any dividend resumption
Settlement of UOB judgment by associate2H2026Cash impact; any further appeal
Refinancing of HK$507m bank loans—Margin and tenor
Any holdco restructuring (HKC/LCR)UnscheduledOffer price versus NAV (unconfirmed)
Singapore hospitality trendsQuarterlyRevPAR; visitor arrivals after the −1.7% 1H2026 decline

Concluding analyst verdict

Hongkong Chinese Limited is a listed shell around one consequential asset: a 50% joint-venture interest in LAAPL, which carries a derived 33.8% look-through stake in OUE Limited. It also lends roughly S$380 million to the same structure. Every material number in HKC's accounts follows from that one exposure. In FY2025 it accounted for 95% of assets and the dominant share of revenue, and it explains a HK$1.9 billion swing in attributable results between FY2021 and FY2024.

On balance-sheet metrics, the company looks unusually safe. Gearing is about 6%, the current ratio is near 4x, and there are no pledges at HKC level. On income metrics, it looks fragile. Recurring revenue fell 59% year on year in 1H2026 as JV interest was waived, interest cover is below one, and dividends have stopped.

The market resolves this tension by applying a discount of roughly 91% to reported NAV. That discount should not be read as mispricing alone. It reflects three things. First, look-through leverage at OUE and LAAPL is real, including share-backed facilities. Second, OUE's Chinese Mainland exposure keeps producing impairments: S$67 million on GPI over FY2025–1H2026, plus share-of-loss charges. Third, minorities have no control over the timing or form of any value realisation, and there is a family-controlled corporate framework with a demonstrated preference for privatisations.

Our synthesis is neutral-to-cautious on fundamentals, with asymmetric event optionality. The operating trajectory at OUE's Singapore core is improving: revenue is up, financing costs are down, and assets are being recycled. If GPI losses taper, the equity-accounted line could normalise in FY2027. Investors should nonetheless treat HKC as a special-situation holding company rather than a compounder. The key monitorables are, in order: OUE's GPI exposure, the associate's settlement of the S$76 million UOB judgment, HKC's refinancing terms, and any structural proposal from the controlling shareholder. A transaction priced with reference to NAV would be transformative. Without one, the discount is likely to persist and returns will depend on the Singapore real-estate cycle.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenureAge (FY2025 AR)Prior / concurrent rolesEducation

Dr. Stephen Riady

Chairman; Executive Director; Executive President since Jan 2015

Director since Sep 1992

65

Chairman and ED of Lippo China Resources (LCR); Executive Chairman and Group CEO of OUE; director of Lippo Capital Group / Holdings / Capital; resigned as Lippo Ltd director Jan 2026

Graduate of University of Southern California; MBA, Golden Gate University; Hon. DBA, Edinburgh Napier University; Hon. University Fellow, HKBU (2006)

Mr. John Luen Wai Lee, BBS, JP

Deputy Chairman (CEO until 7 Jun 2024); Executive Director

Director since Sep 1992

77

Deputy Chairman, LCR; INED of New World Development and UMP Healthcare; director of Lippo and Hennessy; former Hospital Authority member; chaired Queen Elizabeth / HK Children's Hospital governing committees

FCA (ICAEW), FCCA, FCPA (HKICPA); Hon. Fellow, CityU

Mr. Davy Kwok Fai Lee

Chief Executive Officer; Executive Director

Since Jun 2024

67

CEO and ED of LCR; director of Lippo, Hennessy, Lippo Capital; 40+ years with the Lippo group; 30+ years in treasury, corporate administration and governance

BA (First Class), OUHK; MSc Investment Management, HKUST; JD, CUHK; DBA, PolyU; Fellow, CGI and HKCGI

Mr. Brian Riady

Executive Director

Since Mar 2023

35

Deputy CEO and ED of OUE; non-independent NED of OUE REIT Management; ED of LCR; resigned from Lippo board Jan 2026; son of Dr. Stephen Riady

BSc (Political Communication) and BA (Economics), UT Austin; Harvard Business School executive education

Mr. Leon Nim Leung Chan

Non-executive Director (INED until Sep 2004)

Director since Sep 1992

70

Principal partner, Y.T. Chan & Co.; NED of LCR; INED of Midland Holdings; former member of Solicitors Disciplinary Tribunal (1993–2008)

Solicitor (HK 1980, England 1984, Victoria 1985)

Mr. King Fai Tsui

INED; Chairman of Audit, Remuneration and Nomination Committees

Since Sep 2004 (over 9 years)

76

INED of Newton Resources; ex-Big Four (US and HK); resigned Lippo board Jan 2026

MSc Accountancy and BBA (First Class), University of Houston; FCPA, CA ANZ, AICPA

Mr. Edwin Neo

INED

Since Jan 2018 (also 1995–1998)

76

Senior partner, Hoosenally & Neo; notary public; INED of LCR

LLB (Hons) and PCLL, HKU

Ms. Min Yen Goh

INED

Since Dec 2022

65

Managing director, Eng Wah Group; independent director of OUE; INED of LCR; resigned Lippo board Jan 2026

BSc Economics and Finance (High Distinction), Babson College

Ms. Millie Yuen Fun Luk

Company Secretary

————

Governance Overview

ItemAmount (HKD)Source

Director's fee per director (12-month basis, FY2025)

282,000 (raised from 274,800 to 284,400 p.a. from 1 Apr 2025)

FY2025 AR

Committee chairman fee (NEDs)

93,900

FY2025 AR

Committee member fee (NEDs)

60,600

FY2025 AR

Discretionary bonus — Dr. Stephen Riady

3,087,150

FY2025 AR

Discretionary bonus — Mr. Davy Kwok Fai Lee

1,036,400

FY2025 AR

Total Group staff costs incl. directors (FY2025)

approx. 18,000,000 (FY2024: 11,000,000)

FY2025 AR

Directors' Remuneration

AttributeDetail

Board size

8: 4 executive, 1 non-executive, 3 INEDs

Independence

3/8 = 37.5% INEDs, above the one-third Listing Rule floor

Chair/CEO separation

Yes. Chairman Dr. Stephen Riady; CEO Mr. Davy Kwok Fai Lee; roles set out in writing

Gender diversity

1 female director (12.5%)

Audit Committee

Tsui (Chair), Chan, Neo. All non-executive; 3 meetings in FY2025

Remuneration Committee

Tsui (Chair), S. Riady, Chan, Neo, Goh. 3 meetings

Nomination Committee

Tsui (Chair), S. Riady, Chan, Neo, Goh. 3 meetings

Board meetings FY2025

  1. 100% board attendance; Chairman and Brian Riady absent from the 2025 AGM

CG Code deviation

Chairman did not attend the 23 Jun 2025 AGM (travelling overseas); Deputy Chairman presided

Long-tenure INED

Mr. Tsui (since 2004); board affirmed independence

Related-party overlap

All directors except Mr. Tsui also sit on the LCR board, a fellow subsidiary engaged in property investment and development

Board & Management Changes

DateChangeContext

7 Jun 2024

Davy Kwok Fai Lee appointed CEO and ED; John Lee re-designated Deputy Chairman

Succession within Lippo management bench

Jan 2025 / Mar 2025 / Jan 2026

Renewal of letter agreements (two-year terms) for S. Riady, J. Lee, B. Riady, L. Chan, E. Neo

Routine

Jan 2026

S. Riady, B. Riady, L. Chan, K.F. Tsui and M.Y. Goh resigned as directors of Lippo Limited

Follows Lippo Ltd privatisation in Sep 2025

Jun 2026 AGM

S. Riady, E. Neo, J. Lee retire by rotation and offer themselves for re-election.

FY2025 AR; etnet filing list

Major Shareholders

HolderShares%Notes

Lippo Capital Limited (aggregate)

1,179,199,26459.01

Direct 894,916,529 plus indirect 284,282,735

— of which Hennessy Holdings (via Lippo Limited)

284,282,73514.23

Counted within the 59.01%

Mr. John Luen Wai Lee (personal and family)

4,496,1650.23—

Mr. King Fai Tsui (personal and family)

675,0000.03—

Mr. Davy Kwok Fai Lee

9320.00—

Institutions (aggregate)

—

approx. 0.32

S&P GMI via StockAnalysis

Free float (S&P)

approx. 813.9m

approx. 40.7

—

Competitive Landscape

Competitor Detail

LayerCompetitor / comparableListingRelevance

Sister / holding-company comparable

Lippo China Resources Limited

HKEX 0156

Same controller, overlapping board, property investment and development; competing-business disclosure in HKC AR

HK holding companies with SE Asian property / hotels

Keck Seng Investments (Hong Kong)

HKEX 0184

Hotels and property in Asia/US

—

Shun Tak Holdings

HKEX 0242

Property, hospitality, transport

—

Far East Consortium International

HKEX 0035

Hotels (Dorsett), property; bought Oakwood Premier from OUE in 2019

—

Wing Tai Properties

HKEX 0369

HK property / hospitality

—

Hang Lung Group

HKEX 0010

HK/Mainland property holdco (scale benchmark)

Singapore real estate (OUE's arena)

City Developments; UOL Group; Frasers Property; CapitaLand Investment

SGX

Office, hospitality and residential competition

Singapore office REITs (OUE REIT's arena)

Keppel REIT; CapitaLand Integrated Commercial Trust; Suntec REIT

SGX

Grade A CBD office leasing

Healthcare (OUEH's arena)

IHH Healthcare; Raffles Medical Group

Bursa / SGX

Private healthcare in Singapore / China

Peer Comparison FY2025

Metric (FY2025)Hongkong Chinese (0655)OUE Limited (investee)Keck Seng Investments (0184)Shun Tak Holdings (0242)Hang Lung Group (0010)

Revenue

HK$53m

S$617.0m

——

Rental revenue HK$9,853m (−2%)

Revenue growth

−27.0%−4.6%——

Overall revenue −11%

Bottom line

Loss HK$892m

Loss S$279.1m

Profit HK$338.1m (FY2024: 353.5m)

Loss HK$462.6m (FY2024: 749.6m)

—

Dividend

Nil

2.0 Singapore cents

—

Nil (per results)

HK86 cents full-year

R&D intensity

0%

Not applicable

Not applicable

Not applicable

Not applicable

Company Snapshot

$6.8M

Revenue

23

Employees

1992

Founded

Hamilton HM, Bermuda

Headquarters

SWOT Analysis

Strengths

  • Low holding-company leverage. Bank loans of HK$506.7m against attributable equity of HK$8,167.7m, a gearing ratio of 6.2% (1H2026 IR).
  • Unencumbered at HKC level. No charges on Group assets and no material contingent liabilities at 30 June 2026 (1H2026 IR).
  • Liquidity cushion. Current ratio of 3.8x; cash of HK$84.7m against current liabilities of HK$48.3m (1H2026 IR).
  • Quality underlying assets. OUE REIT owns OUE Bayfront, One Raffles Place and OUE Downtown Office, with 95.4% committed office occupancy (FY2025 AR).
  • Investee operating momentum. OUE 1H2026 revenue rose 5.3% to S$308.3m, with real estate up 5.5% to S$205.1m (OUE press release, 14 Aug 2026).
  • Hospitality franchise strength. CPCA was named World's Best Airport Hotel for ten consecutive years at the Skytrax awards (FY2025 AR).
  • Committed sponsor. Riady family interests control 59.01% and run OUE directly; Stephen Riady is Executive Chairman and Group CEO of OUE (FY2025 AR).

Weaknesses

  • Concentration. Interests in JVs make up 95.0% of total assets (derived, 1H2026).
  • Earnings volatility. Attributable result swung from +HK$670m (FY2021) to −HK$1,200m (FY2024) (S&P GMI).
  • Customer concentration. The largest customer is 62% of revenue and the top five 84% (FY2025 AR).
  • Shrinking recurring income. Interest income from loans fell from HK$31.2m in 1H2025 to HK$11.4m in 1H2026 (1H2026 IR).
  • Weak interest coverage. EBIT/interest of 0.66x in FY2025 (derived).
  • Dividend suspended. No dividends for FY2024, FY2025 or the 1H2026 interim (FY2025 AR; 1H2026 IR).
  • Governance optics. The Chairman missed the 2025 AGM. One INED has served more than 9 years. Only 1 of 8 directors is female. Seven of eight directors sit on LCR (FY2025 AR).

Opportunities

  • NAV discount closure. HK$0.38 share price against HK$4.1 NAV is about a 91% discount (derived), with P/B of 0.09x (S&P). Any corporate action at NAV-related value would be highly accretive.
  • OUE capital recycling. The Crowne Plaza Changi sale proposal and the First REIT Indonesia divestment could crystallise value and reduce leverage (1H2026 IR).
  • Healthcare ramp. Prince Bay Hospital opened July 2026, and OUEH privatisation could simplify the structure (1H2026 IR).
  • Singapore macro upgrade. The 2026 GDP forecast was raised to 4.5–5.5% (1H2026 IR).
  • Lower holding costs. Re-domiciliation to Hong Kong is aimed at removing dual-jurisdiction costs (1H2026 IR).
  • Easing rates. FY2025 finance costs fell to HK$23m from HK$32m on lower rates (FY2025 AR). Further cuts would help the floating-rate HK$507m loan.

Threats

  • Further GPI losses. OUE booked a S$47.0m GPI impairment in 1H2026 on top of S$20m in FY2025 (OUE filings). HKC's share of JV losses was HK$430m in 1H2026.
  • Litigation cash cost at associate. The S$76.1m (≈HK$466m) UOB judgment of August 2026 (1H2026 IR).
  • Secured share pledges at LAAPL. Certain bank facilities are secured on listed shares, so a sharp fall in OUE or OUE REIT prices could trigger collateral pressure (1H2026 IR, Note 7).
  • Geopolitical and energy shock. Middle East conflict and Strait of Hormuz disruptions are flagged as downside risks (1H2026 IR).
  • Tourism softening. Singapore visitor arrivals fell 1.7% in 1H2026 (1H2026 IR).
  • Minority-shareholder risk. The controlling family's precedent of privatising subsidiaries (Lippo Ltd in 2025; OUEH proposed in 2026) raises the possibility of a take-private at a price well below NAV (analytical inference).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025FY2024 Annual Report published, confirming the HK$1,200m lossConfirms the FY2024 trough
May 2025Groundwork begins on Hotel Indigo Changi Airport (OUE 51%)Long-dated growth asset
Jun 2025Singapore High Court assesses damages of approx. S$17.7m against the Marina Collection associate in the UOB caseContingent liability crystallises
23 Jun 2025AGM; all resolutions passed; Chairman absent (CG Code deviation)Governance note
1 Jul 2025JV shareholders stop accruing interest on part of the FCL loansRevenue reset
Jul–Aug 2025Positive profit alert for 1H2025Sentiment
14 Aug 2025OUE 1H2025 profit of S$35.6m, aided by S$94.9m provisional negative goodwill on GPIDrove HKC's 1H2025 profit
28 Aug 2025HKC 1H2025 results: profit HK$199.5m vs loss HK$421.6m; EPS 10.0 cents; no interim dividendTemporary swing
23–25 Sep 2025Lippo Limited scheme effective; delistedChange in parent structure
29 Sep 20252025 Interim Report publishedRoutine
Dec 2025OUE lifts its OUEH stake to 89.68%Healthcare consolidation
Dec 2025HKC adopts Workforce Diversity Policy; revises committee terms of referenceGovernance
Jan 2026Several HKC directors resign from the Lippo Limited boardPost-privatisation clean-up
4 Feb 2026UOB appeals the quantum of damages to the Appellate Division; hearing set for May 2026Risk escalation
13 Feb 2026Inside information: OUE expects an FY2025 loss; HKC expects share of JV losses of HK$800m–1.0bnEarly warning
27 Feb 2026OUE FY2025: revenue S$617.0m (−4.6%), loss S$279.1m; NAV S$3.85/share; dividend 2.0 Singapore centsInvestee performance
Mar 2026OUE REIT completes the Salesforce Tower 19.9% acquisition; O2 SleepWell Lab launchedDiversification
Mar 2026HKC revises Dividend Policy and Anti-corruption PolicyGovernance
26 Mar 2026Profit warning: FY2025 loss of about HK$0.9bnConfirms second loss year
31 Mar 2026FY2025 results: loss HK$892m; NAV HK$4.4/share; no dividendKey filing
29 Apr 2026FY2025 Annual Report publishedKey filing
May 2026Appellate Division hears the UOB quantum appealLitigation
8 Jun 2026AGM poll results; re-domiciliation to Hong Kong approved by special resolutionCorporate change
Jun 2026OUE proposes JV acquisition of Crowne Plaza Changi from OUE REIT; First REIT EGM approves Indonesia divestmentCapital recycling
24 Jul 2026Prince Bay Hospital, Shenzhen officially opens (OUEH JV)Healthcare ramp-up
31 Jul 2026Inside information: OUE 1H2026 profit guidance; HKC expects share of JV loss of HK$290–470mEarly warning
14 Aug 2026OUE 1H2026: revenue S$308.3m (+5.3%); loss S$114.6m incl. S$47.0m GPI impairment. HKC issues profit warning the same dayInvestee performance
Aug 2026Appellate Division awards UOB approx. S$76.1m (≈HK$466m) plus costsMajor adverse ruling
24 Aug 2026HKC inside information: expected 1H2026 loss of about HK$570m incl. HK$126m share of associate loss. OUE proposes OUEH privatisationEarnings hit
28 Aug 2026HKC 1H2026 results: loss HK$569.5m; EPS −28.5 cents; NAV HK$4.1; no interim dividendLatest filing
NextEstimated next results date (aggregator): FY2026 results expected about March 2027. S&P's 27 Nov 2026 date appears to be a placeholderMonitor

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Revenue by Segment (FY2024–FY2025): Total revenue fell from HKD 72.9 Mn in FY2024 to HKD 53.2 Mn in FY2025.
Hongkong Chinese Limited — Revenue by Segment (FY2024–FY2025)
Series (HKD Mn)FY2024FY2025
Total revenue72.953.2
Property investment revenue7050
All other segments combined revenue2.93.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Hongkong Chinese Limited, 2025 Annual Report (HKEXnews, 29 Apr 2026)
  2. Hongkong Chinese Limited, Interim Results for six months ended 30 Jun 2026 (28 Aug 2026)
  3. Hongkong Chinese Limited, 2025 Interim Report (29 Sep 2025)
  4. HKC profit warning, 26 Mar 2026
  5. HKC profit warning, 14 Aug 2026
  6. HKC inside information, 24 Aug 2026
  7. HKC inside information (Chinese), 31 Jul 2026
  8. HKC board meeting notices, 19 Mar 2026 and 18 Aug 2026 (HKEXnews)
  9. HKC announcement on distribution in specie, 27 Dec 2024
  10. Lippo/HKC joint announcement on UOB litigation, Nov 2022
  11. LL Capital / Lippo Limited scheme sanction announcement, 19 Sep 2025
  12. OUE Limited 1H2026 results and press release (SGX, 14 Aug 2026): OUE 1H2026 profit guidance (31 Jul 2026) · OUE FY2025 financial results (oue.com.sg)
  13. The Edge Singapore, OUE FY2025 results coverage; iFAST/FSMOne note on OUE green bond
  14. StockAnalysis.com (S&P Global Market Intelligence data): income statement, balance sheet, cash flow and statistics pages for HKG:0655 (accessed Oct 2026)
  15. Tiger Brokers / Reuters briefs on HKC 1H2025 results and Feb 2026 announcements: TipRanks HKC pages
  16. Historical: HKC 2002 Interim and Annual Reports · Lippo Limited 2005 Annual Report · HKC 2006 Annual Report · PropertyGuru (Mar and May 2010) · Webb-site.com HKCB commentary · HK Government press release (26 Aug 2005) · Wikipedia entries for Hongkong Chinese Limited, Hongkong Chinese Bank and Lippo Limited
  17. Peer data: Keck Seng Investments 2025 final results (HKEX, 24 Mar 2026) · Shun Tak Holdings 2025 annual results · Hang Lung Group 2025 annual results (HKEX, 30 Jan 2026)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.